BRTX Stock Price Increased 30% Today: Why It Happened – Pulse 2.0

The stock price of BioRestorative Therapies Inc (OTCMKTS: BRTX) a company that develops therapeutic products using cell and tissue protocols primarily involving adult stem cells increased by 30% today as it went from $0.010 in the previous close to a day high of $0.013 today. One of the biggest triggers appears to be tweets from an account that is associated with the new CEO of the company Lance Alstodt:

About three weeks ago, it was announced that BioRestorative Therapies was emerging from Chapter 11 reorganization. And pursuant to the confirmed plan of reorganization, the company received $3.848 million in financing. The confirmed plan of reorganization also provides for additional funding, subject to certain conditions of $3.5 million less the sum of the debtor-in-possession financing provided to the company during the reorganization (approximately $1.227 million) and the costs incurred by the debtor-in-possession lender.

As part of the reorganization Lance Alstodt was appointed the companys President, Chief Executive Officer, and Chairman of the Board. And based upon the companys emergence from Chapter 11 reorganization, FINRA has removed the Q at the end of its trading symbol.

This process has been a long and challenging journey for the Company. Im inspired by the great resolve and execution from our employees, professionals, and investors. We are very pleased that all requirements have been met for us to emerge. Allowed creditor claims have been fully satisfied and, as importantly, our equity holders have retained their shares in this exciting new opportunity. We were able to preserve all of our intellectual property assets and look forward to initiating our Phase 2 clinical trial, said Alstodt in a statement at the time.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.

Read the original:

BRTX Stock Price Increased 30% Today: Why It Happened - Pulse 2.0